NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Pacira BioSciences, Inc. (“Pacira” or the “Company”) (NASDAQ:PCRX) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Pacira investors who were adversely affected by alleged securities fraud between August 2, 2023 and August 8, 2024. Follow the link below to get more information and be contacted by a member of our team:
https://zlk.com/pslra-1/pacira-biosciences-inc-lawsuit-submission-form?prid=132368&wire=3
PCRX investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
CASE DETAILS: According to the complaint, on August 9, 2024, Pacira issued a press release announcing the results of its lawsuit against eVenus for patent infringement. Pacira disclosed that the court “found that the company’s U.S. Patent …
